- Home
- AMRC vs GHRS Comparison
AMRC vs GHRS Comparison
Compare AMRC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRC
- GHRS
- Stock Information
- Founded
- AMRC 2000
- GHRS 2018
- Country
- AMRC United States
- GHRS Ireland
- Employees
- AMRC N/A
- GHRS N/A
- Industry
- AMRC Engineering & Construction
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- AMRC Consumer Discretionary
- GHRS Health Care
- Exchange
- AMRC Nasdaq
- GHRS Nasdaq
- Market Cap
- AMRC 1.1B
- GHRS 868.7M
- IPO Year
- AMRC 2010
- GHRS 2021
- Fundamental
- Price
- AMRC $18.70
- GHRS $12.51
- Analyst Decision
- AMRC Strong Buy
- GHRS Strong Buy
- Analyst Count
- AMRC 10
- GHRS 3
- Target Price
- AMRC $36.88
- GHRS $35.67
- AVG Volume (30 Days)
- AMRC 324.2K
- GHRS 1.1M
- Earning Date
- AMRC 02-27-2025
- GHRS 03-07-2025
- Dividend Yield
- AMRC N/A
- GHRS N/A
- EPS Growth
- AMRC 13.70
- GHRS N/A
- EPS
- AMRC 1.00
- GHRS N/A
- Revenue
- AMRC $1,678,629,000.00
- GHRS N/A
- Revenue This Year
- AMRC $30.51
- GHRS N/A
- Revenue Next Year
- AMRC $10.70
- GHRS N/A
- P/E Ratio
- AMRC $18.67
- GHRS N/A
- Revenue Growth
- AMRC 32.70
- GHRS N/A
- 52 Week Low
- AMRC $17.55
- GHRS $6.00
- 52 Week High
- AMRC $39.68
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- AMRC 34.23
- GHRS 51.44
- Support Level
- AMRC $18.65
- GHRS $13.50
- Resistance Level
- AMRC $19.83
- GHRS $14.91
- Average True Range (ATR)
- AMRC 0.92
- GHRS 1.58
- MACD
- AMRC -0.03
- GHRS -0.22
- Stochastic Oscillator
- AMRC 2.65
- GHRS 5.56
About AMRC Ameresco Inc.
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of revenue from the U.S. Regions segment.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.